355 related articles for article (PubMed ID: 12052029)
1. Discovery of endocannabinoids and some random thoughts on their possible roles in neuroprotection and aggression.
Mechoulam R
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):93-9. PubMed ID: 12052029
[TBL] [Abstract][Full Text] [Related]
2. Endocannabinoids in the central nervous system--an overview.
Fride E
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):221-33. PubMed ID: 12052038
[TBL] [Abstract][Full Text] [Related]
3. Endocannabinoids and the gut.
Pinto L; Capasso R; Di Carlo G; Izzo AA
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):333-41. PubMed ID: 12052047
[TBL] [Abstract][Full Text] [Related]
4. Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide.
Gonsiorek W; Lunn C; Fan X; Narula S; Lundell D; Hipkin RW
Mol Pharmacol; 2000 May; 57(5):1045-50. PubMed ID: 10779390
[TBL] [Abstract][Full Text] [Related]
5. Endocannabinoid structure-activity relationships for interaction at the cannabinoid receptors.
Reggio PH
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):143-60. PubMed ID: 12052032
[TBL] [Abstract][Full Text] [Related]
6. Endocannabinoids.
Mechoulam R; Fride E; Di Marzo V
Eur J Pharmacol; 1998 Oct; 359(1):1-18. PubMed ID: 9831287
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoid receptors and their ligands.
Pertwee RG; Ross RA
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):101-21. PubMed ID: 12052030
[TBL] [Abstract][Full Text] [Related]
8. The promise of advances in the field of endocannabinoids.
Mechoulam R
Neuro Endocrinol Lett; 2004; 25(1-2):11-2. PubMed ID: 15159675
[No Abstract] [Full Text] [Related]
9. Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor.
Porter AC; Sauer JM; Knierman MD; Becker GW; Berna MJ; Bao J; Nomikos GG; Carter P; Bymaster FP; Leese AB; Felder CC
J Pharmacol Exp Ther; 2002 Jun; 301(3):1020-4. PubMed ID: 12023533
[TBL] [Abstract][Full Text] [Related]
10. Endocannabinoids: new targets for drug development.
Di Marzo ; Bisogno T; De Petrocellis L
Curr Pharm Des; 2000 Sep; 6(13):1361-80. PubMed ID: 10903398
[TBL] [Abstract][Full Text] [Related]
11. Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications.
Snider NT; Walker VJ; Hollenberg PF
Pharmacol Rev; 2010 Mar; 62(1):136-54. PubMed ID: 20133390
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoids and the gut: new developments and emerging concepts.
Izzo AA; Sharkey KA
Pharmacol Ther; 2010 Apr; 126(1):21-38. PubMed ID: 20117132
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoids and brain injury: therapeutic implications.
Mechoulam R; Panikashvili D; Shohami E
Trends Mol Med; 2002 Feb; 8(2):58-61. PubMed ID: 11815270
[TBL] [Abstract][Full Text] [Related]
14. Neuroscience. Stout guards of the central nervous system.
Mechoulam R; Lichtman AH
Science; 2003 Oct; 302(5642):65-7. PubMed ID: 14526067
[TBL] [Abstract][Full Text] [Related]
15. 'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance.
Di Marzo V
Biochim Biophys Acta; 1998 Jun; 1392(2-3):153-75. PubMed ID: 9630590
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoids biology: the search for new therapeutic targets.
Felder CC; Dickason-Chesterfield AK; Moore SA
Mol Interv; 2006 Jun; 6(3):149-61. PubMed ID: 16809476
[TBL] [Abstract][Full Text] [Related]
17. Anandamide may mediate sleep induction.
Mechoulam R; Fride E; Hanus L; Sheskin T; Bisogno T; Di Marzo V; Bayewitch M; Vogel Z
Nature; 1997 Sep; 389(6646):25-6. PubMed ID: 9288961
[No Abstract] [Full Text] [Related]
18. Cannabimimetic plants: are they new cannabinoidergic modulators?
Kumar A; Premoli M; Aria F; Bonini SA; Maccarinelli G; Gianoncelli A; Memo M; Mastinu A
Planta; 2019 Jun; 249(6):1681-1694. PubMed ID: 30877436
[TBL] [Abstract][Full Text] [Related]
19. The endocannabinoid system as a target for therapeutic drugs.
Piomelli D; Giuffrida A; Calignano A; RodrÃguez de Fonseca F
Trends Pharmacol Sci; 2000 Jun; 21(6):218-24. PubMed ID: 10838609
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid activation of PPAR alpha; a novel neuroprotective mechanism.
Sun Y; Alexander SP; Garle MJ; Gibson CL; Hewitt K; Murphy SP; Kendall DA; Bennett AJ
Br J Pharmacol; 2007 Nov; 152(5):734-43. PubMed ID: 17906680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
